Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole (OPC-34712) in acute schizophrenia
NCT00905307Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jul 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of brexpiprazole orally disintegrating tablet in schizophrenia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Jul 2009; status: completed.
02
Drugs
brexpiprazole orally disintegrating tablet
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00905307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00905307.